Atogepant, the first oral preventive treatment for chronic migraine

Kristian A Haanes; Lars Edvinsson

doi:10.1016/S0140-6736(23)01462-9

Atogepant, the first oral preventive treatment for chronic migraine

Kristian A Haanes^*, Lars Edvinsson

^*Corresponding author af dette arbejde

Klinisk Eksperimentel Forskningsafdeling, Glostrup

2 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Lancet
Vol/bind	402
Udgave nummer	10404
Sider (fra-til)	748-749
Antal sider	2
ISSN	0140-6736
DOI	https://doi.org/10.1016/S0140-6736(23)01462-9
Status	Udgivet - 2 sep. 2023

Adgang til dokumentet

10.1016/S0140-6736(23)01462-9

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{783326bbabc14a38bf685f6cfcac0642,

title = "Atogepant, the first oral preventive treatment for chronic migraine",

keywords = "Administration, Oral, Calcitonin Gene-Related Peptide, Humans, Migraine Disorders/drug therapy, Piperidines/therapeutic use",

author = "Haanes, {Kristian A} and Lars Edvinsson",

year = "2023",

month = sep,

day = "2",

doi = "10.1016/S0140-6736(23)01462-9",

language = "English",

volume = "402",

pages = "748--749",

journal = "Lancet",

issn = "0140-6736",

publisher = "The/Lancet Publishing Group",

number = "10404",

}

TY - JOUR

T1 - Atogepant, the first oral preventive treatment for chronic migraine

AU - Haanes, Kristian A

AU - Edvinsson, Lars

PY - 2023/9/2

Y1 - 2023/9/2

KW - Administration, Oral

KW - Calcitonin Gene-Related Peptide

KW - Humans

KW - Migraine Disorders/drug therapy

KW - Piperidines/therapeutic use

UR - http://www.scopus.com/inward/record.url?scp=85168978485&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(23)01462-9

DO - 10.1016/S0140-6736(23)01462-9

M3 - Comment/debate

C2 - 37516124

SN - 0140-6736

VL - 402

SP - 748

EP - 749

JO - Lancet

JF - Lancet

IS - 10404

ER -